CIHR-Transcan: Translational Research on Cancer Epigenetics
Research Admin Offices:
- HRS
Funding Type:
GrantOpportunity Type:
- Grant
Value:
Up to $450,000 over three years for the Canadian partner.
Disciplines:
- Health Sciences
Sponsors:
Deadlines:
Internal Deadline:
July 6, 2023Sponsor Deadline:
July 20, 2023Additional Dates:
- Preproposal HRS Due Date - July 6, 2023
- Preproposal Sponsor Due Date - July 20, 2023
- Application Sponsor Due Date (by invitation) - December 14, 2023
Description:
This opportunity supports cancer research to improve the efficacy of current detection, diagnosis, prognosis and treatment of cancers, through the development of novel approaches based on a better understanding of cancer epigenetics via partnerships between researchers and clinicians.
Resources:
Contact:
If applying from the Faculty of Health Sciences, unless otherwise indicated, you no longer need to send documents to HRS Intake. Your first point of contact is your assigned Senior Grants Advisor.